Association between plasma inflammatory markers and irrational beliefs; the ATTICA epidemiological study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 8, 2006, Pages 1496-1503

  Papageorgiou, Charalabos ^a   Panagiotakos, Demosthenes B ^b   Pitsavos, Christos ^a   Tsetsekou, Efi ^a   Kontoangelos, Kostantinos ^a   Stefanadis, Christodoulos ^a   Soldatos, Constantin ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Cardiovascular disease; Depression; Immune system; Inflammatory factors; Irrational beliefs

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOOD INTAKE; HUMAN; INFLAMMATION; IRRATIONAL BELIEF INVENTORY; LEUKOCYTE COUNT; MALE; MEDICAL ASSESSMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SAMPLE SIZE; SELF REPORT; SEX RATIO; ZUNG DEPRESSION QUESTIONNAIRE;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CULTURE; DEPRESSION; FEMALE; GREECE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SERUM AMYLOID A PROTEIN;

EID: 33750298151     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.05.018     Document Type: Article

References (54)

1. Alden L., and Safran J. Irrational beliefs and non assertive behavior. Cognit Ther Res 2 (1978) 357-364
2. Anisman H., Hayley S., Turrin N., and Merali Z. Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol 5 (2002) 357-373
3. Anisman H., and Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 35 (2003) 2-11
4. Appels A., Kop W.J., and Schouten E. The nature of the depressive symptomatology preceding myocardial infarction. Behav Med 26 (2000) 86-89
5. Ariyo A.A., Haan M., Tangen C.M., Rutledge J.C., Cushman M., Dobs A., et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102 (2000) 1773-1779
6. Atanackovic D., Kroger H., Serke S., and Deter H.C. Immune parameters in patients with anxiety or depression during psychotherapy. J Affect Disord 81 (2004) 201-209
7. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 (2003) s119-s124 [Suppl.]
8. Capuron L., Hauser P., Hinze-Selch D., Miller A.H., and Neveu P.J. Treatment of cytokine-induced depression. Brain Behav Immun 16 (2002) 575-580
9. Carney R.M., and Freedland K.E. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 54 (2003) 241-247
10. Day L., and Maltby J. Belief in good luck and psychological well-being: the mediating role of optimism and irrational beliefs. J Psychol 137 (2003) 99-110
11. Ellis A. Reason and emotion in psychotherapy (1962), Lyle Stuart, New York
12. Ellis A. The revised ABC's of rational-emotive therapy (RET). J Ration Emot Cogn Behav Ther 9 (1991) 139-172
13. Ellis A. Why rational-emotive therapy to rational emotive behavior therapy?. Psychotherapy 36 (1999) 154-159
14. Gaughran F. Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int Rev Neurobiol 52 (2002) 275-302
15. Grippo A.J., and Johnson A.K. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 26 (2002) 941-962
16. Harro J., and Oreland L. Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Brain Res Rev 38 (2001) 79-128
17. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 62 (2001) 77-91
18. Hosaka T., and Sugiyama Y. Structured intervention in family caregivers of the demented elderly and changes in their immune function. Psychiatry Clin Neurosci 57 (2003) 147-151
19. Ignatowski T.A., Noble B.K., Wright J.R., Gorfien J.L., Heffner R.R., and Spengler R.N. Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J Neuroimmunol 79 (1997) 84-90
20. Joynt K.E., Whellan D.J., and O'Connor C.M. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 54 (2003) 248-261
21. Kamata M., Higuchi H., Yoshimoto M., Yoshida K., and Shimizu T. Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain. Eur Neuropsychopharmacol 10 (2000) 129-132
22. Katsouyanni K., Rimm E.B., Gnardellis C., Trichopoulos D., Polychronopoulos E., and Trichopoulou A. Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. Int J Epidemiol 26 (1997) 118-127
23. Kendall P.C., Haaga D.A., Ellis A., Bernard M., DiGiuseppe R., and Kassinove H. Rational-emotive therapy in the 1990s and beyond: current status, recent revisions, and research questions. Clin Psychol Rev 15 (1999) 169-185
24. Kenis G., and Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5 (2002) 401-412
25. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103 (2001) 1064-1070
26. Koenig H.G., Cohen H.J., George L.K., Hays J.C., Larson D.B., and Blazer D.G. Attendance at religious services, interleukin-6, and other biological parameters of immune function in older adults. Int J Psychiatry Med 27 (1997) 233-250
27. Kop W.J. The integration of cardiovascular behavioral medicine and psychoneuroimmunology: new developments based on converging research fields. Brain Behav Immun 17 (2003) 233-237
28. Lestage J., Verrier D., Palin K., and Dantzer R. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun 16 (2002) 596-601
29. Lord R.S., and Bobryshev Y.V. Hallmarks of atherosclerotic lesion development with special reference to immune inflammatory mechanisms. Cardiovasc Surg 10 (2002) 405-414
30. Lutgendorf S.K., Russell D., Ullrich P., Harris T.B., and Wallace R. Religious participation, interleukin-6, and mortality in older adults. Health Psychol 23 (2004) 465-475
31. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
32. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19 (1995) 11-38
33. McNaughton M.E., Patterson T.L., Smith T.L., and Grant I. The relationship among stress, depression, locus of control, irrational beliefs, social support, and health in Alzheimer's disease caregivers. J Nerv Ment Dis 183 (1995) 78-85
34. Mulvihill N.T., and Foley J.B. Inflammation in acute coronary syndromes. Heart 87 (2002) 201-204
35. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Tsetsekou E., Papageorgiou C., Christodoulou G., et al. ATTICA study. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 25 (2002) 492-499
36. Papanicolaou D.A., Wilder R.L., Manolagas S.C., and Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128 (1998) 127-137
37. Pariante C.M. Depression, stress and the adrenal axis. J Neuroendocrinol 15 (2003) 811-812
38. Pasic J., Levy W.C., and Sullivan M.D. Cytokines in depression and heart failure. Psychosom Med 65 (2003) 181-193
39. Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58 (2001) 221-227
40. Peters M.L., Godaert G.L., Ballieux R.E., and Heijnen C.J. Moderation of physiological stress responses by personality traits and daily hassles: less flexibility of immune system responses. Biol Psychol 65 (2003) 21-48
41. Pollak Y., and Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5 (2002) 389-399
42. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
43. Schwarz M.J., Chiang S., Muller N., and Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav Immun 15 (2001) 340-370
44. Sluzewska A. Indicators of immune activation in depressed patients. Adv Exp Med Biol 461 (1999) 59-73
45. Smith T.W., and Ruiz J.M. Psychosocial influences on the development and course of coronary heart disease: current status and implications for research and practice. J Consult Clin Psychol 70 (2002) 548-568
46. Solomon A., Arnow B.A., Gotlib I.H., and Wind B. Individualized measurement of irrational beliefs in remitted depressives. J Clin Psychol 59 (2003) 439-455
47. Steptoe A., Owen N., Kunz-Ebrecht S.R., and Brydon L. Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middle-aged men and women. Psychoneuroendocrinology 29 (2004) 593-611
48. Strike P.C., and Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis 46 (2004) 337-347
49. Watson P.J., Morris R.J., and Miller L. Irrational beliefs, attitudes about competition, and splitting. J Clin Psychol 57 (2001) 343-354
50. Wichers M.C., and Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 29 1 (2004) 11-17
51. Wilson C.J., Finch C.E., and Cohen H.J. Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50 (2002) 2041-2056
52. Ziegler D.J., and Leslie Y.M. A test of the ABC model underlying rational emotive behavior therapy. Psychol Rep 92 (2003) 235-240
53. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15 (2001) 199-226
54. Zung W. A self-rating depression scale. Arch Gen Psychiatry 12 (1965) 63-70